Triple-drug therapy vs the dual therapies resulted in greater mean reduction in SeBP ( Hispanic/Latino : 35.0 / 20.9 mm Hg vs 27.8-30 .9 / 15.3-17 .7 mm Hg ; non-Hispanic/Latino : 39.0 / 21.7 mm Hg vs 28.9-31 .5 / 14.6-17 .8 mm Hg ) and enabled more participants to reach BP goal ( Hispanic/Latino : 56.8 % vs 40.6 % -51.2 % ; non-Hispanic/Latino : 65.7 % vs 33.8 % -46.6 % ) irrespective of ethnicity .